UBS/PUT/PFIZER INC/32.5/0.1/20.09.24 Share Price

Warrant

CH1280725610

Market Closed - Deutsche Boerse AG 10:10:17 03/07/2024 pm IST
0.45 EUR +2.27% Intraday chart for UBS/PUT/PFIZER INC/32.5/0.1/20.09.24
Current month+4.65%
1 month+32.35%
Date Price Change
03/24/03 0.45 +2.27%
02/24/02 0.44 +7.32%
01/24/01 0.41 -4.65%
28/24/28 0.43 -4.44%
27/24/27 0.45 -6.25%

Delayed Quote Deutsche Boerse AG

Last update July 03, 2024 at 10:10 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying PFIZER, INC.
Issuer UBS
WKN UL4A45
ISINCH1280725610
Date issued 11/07/2023
Strike 32.5 $
Maturity 20/09/2024 (79 Days)
Parity 10 : 1
Emission price 0.22
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.71
Lowest since issue 0.138
Spread 0.05
Spread %10.00%

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
27.7 USD
Average target price
31.92 USD
Spread / Average Target
+15.22%
Consensus